<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 27 Apr 2021 23:26:52 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>潜力品种Top 10排行，单抗药物一马当先！</title><link>https://mp.weixin.qq.com/s/AFkrYrCDvoNq2strEFwEyg</link><description></description><content:encoded><![CDATA[潜力品种Top 10排行，单抗药物一马当先！]]></content:encoded><pubDate>Tue, 27 Apr 2021 21:39:29 +0800</pubDate></item><item><title>27个大品种联动降价，涉及齐鲁、扬子江、天晴...</title><link>https://mp.weixin.qq.com/s/gNWVZAKgGtWMCfq2HU-5Zw</link><description></description><content:encoded><![CDATA[27个大品种联动降价，涉及齐鲁、扬子江、天晴...]]></content:encoded><pubDate>Tue, 27 Apr 2021 21:39:29 +0800</pubDate></item><item><title>化工巨头调价开始，涨价潮已来！停航停运，​运价暴涨450%！</title><link>https://mp.weixin.qq.com/s/X8kxm-L6STlqkn15Zbiqsg</link><description></description><content:encoded><![CDATA[化工巨头调价开始，涨价潮已来！停航停运，​运价暴涨450%！]]></content:encoded><pubDate>Tue, 27 Apr 2021 21:39:29 +0800</pubDate></item><item><title>省际联盟集采再启航，注射剂「霸屏」</title><link>https://mp.weixin.qq.com/s/ho2qajDuPhat6HUYyOImig</link><description></description><content:encoded><![CDATA[省际联盟集采再启航，注射剂「霸屏」]]></content:encoded><pubDate>Tue, 27 Apr 2021 21:39:29 +0800</pubDate></item><item><title>基药目录释放信号，五个重点方向值得关注！</title><link>https://mp.weixin.qq.com/s/imK7cXaJQ2Pto7k4M52alA</link><description></description><content:encoded><![CDATA[基药目录释放信号，五个重点方向值得关注！]]></content:encoded><pubDate>Tue, 27 Apr 2021 21:39:29 +0800</pubDate></item><item><title>（2021.4.26）最新过评名单，5品种首家冲线...</title><link>https://mp.weixin.qq.com/s/70oFLxhNrf1NnSyFAc3FBg</link><description></description><content:encoded><![CDATA[（2021.4.26）最新过评名单，5品种首家冲线...]]></content:encoded><pubDate>Mon, 26 Apr 2021 21:41:15 +0800</pubDate></item><item><title>500品种集采步步推进，针剂药品“蜕变”成主角！</title><link>https://mp.weixin.qq.com/s/RsI95Ape04STx3e56HdVrQ</link><description></description><content:encoded><![CDATA[500品种集采步步推进，针剂药品“蜕变”成主角！]]></content:encoded><pubDate>Mon, 26 Apr 2021 21:41:15 +0800</pubDate></item><item><title>千余个药品将失去院内销售市场</title><link>https://mp.weixin.qq.com/s/693OaGsMjSTFyVTw6H0esA</link><description></description><content:encoded><![CDATA[千余个药品将失去院内销售市场]]></content:encoded><pubDate>Mon, 26 Apr 2021 21:41:15 +0800</pubDate></item><item><title>CDE：第二批已上市药品说明书增加儿童用药信息公开征求意见</title><link>https://mp.weixin.qq.com/s/xfSC3UM1I_1JSRVGkAjeTA</link><description></description><content:encoded><![CDATA[CDE：第二批已上市药品说明书增加儿童用药信息公开征求意见]]></content:encoded><pubDate>Mon, 26 Apr 2021 21:41:15 +0800</pubDate></item><item><title>「吗丁啉」优势不再，国产仿制大有接管市场之意！</title><link>https://mp.weixin.qq.com/s/jKdzMGudNgLP-ihKbykYvQ</link><description></description><content:encoded><![CDATA[「吗丁啉」优势不再，国产仿制大有接管市场之意！]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>美托洛尔：两种酸根，相隔大半个市场</title><link>https://mp.weixin.qq.com/s/fqB8NJJ9Z5UJKww8MnPTSA</link><description></description><content:encoded><![CDATA[美托洛尔：两种酸根，相隔大半个市场]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>422个药品，拟调入（出）短缺药目录</title><link>https://mp.weixin.qq.com/s/9mA1rArIli3nwU964uU2og</link><description></description><content:encoded><![CDATA[422个药品，拟调入（出）短缺药目录]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>原料药垄断再掀风波，谁懂制剂企业背后的辛酸点滴？</title><link>https://mp.weixin.qq.com/s/usop2swNjaKrBZXmlXgCcg</link><description></description><content:encoded><![CDATA[原料药垄断再掀风波，谁懂制剂企业背后的辛酸点滴？]]></content:encoded><pubDate>Sun, 25 Apr 2021 21:41:51 +0800</pubDate></item><item><title>“开挂”的印度制药，却是凭实力仿的药！</title><link>https://mp.weixin.qq.com/s/bnBmsyQeOfZZYwO_-E8awQ</link><description></description><content:encoded><![CDATA[“开挂”的印度制药，却是凭实力仿的药！]]></content:encoded><pubDate>Sat, 24 Apr 2021 21:36:56 +0800</pubDate></item><item><title>最新一致性评价目录，注射剂大获全胜！</title><link>https://mp.weixin.qq.com/s/_PE66HO47kPcTu48h7szQg</link><description></description><content:encoded><![CDATA[最新一致性评价目录，注射剂大获全胜！]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>一大批品种动态调价，最高降幅63.5%！</title><link>https://mp.weixin.qq.com/s/NH77EVRvThWxG6pnLh5hsw</link><description></description><content:encoded><![CDATA[一大批品种动态调价，最高降幅63.5%！]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>165个药品取消挂网</title><link>https://mp.weixin.qq.com/s/ckokw55PSNEzsLsk5k0Dzw</link><description></description><content:encoded><![CDATA[165个药品取消挂网]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>【FDA】ICH-Q8,Q9,Q10注册技术要点</title><link>https://mp.weixin.qq.com/s/_f4KgmamkiQHXxuUM8y_yg</link><description></description><content:encoded><![CDATA[【FDA】ICH-Q8,Q9,Q10注册技术要点]]></content:encoded><pubDate>Fri, 23 Apr 2021 21:45:39 +0800</pubDate></item><item><title>微球技术哪家强？且看四大领头玩家强势领跑</title><link>https://mp.weixin.qq.com/s/BRaQZmAmbNEn61SSACNAVw</link><description></description><content:encoded><![CDATA[微球技术哪家强？且看四大领头玩家强势领跑]]></content:encoded><pubDate>Thu, 22 Apr 2021 21:41:57 +0800</pubDate></item><item><title>抗凝新力军 - 艾多沙班，踏上“医保”的巨轮乘风破浪吧！</title><link>https://mp.weixin.qq.com/s/9xy7nhcFg0Cjbx40lLukPw</link><description></description><content:encoded><![CDATA[抗凝新力军 - 艾多沙班，踏上“医保”的巨轮乘风破浪吧！]]></content:encoded><pubDate>Thu, 22 Apr 2021 21:41:57 +0800</pubDate></item></channel></rss>